Biophotonic Solutions Inc., an East Lansing, MI-based provider of automated laser pulse compression solutions, closed a $1m Series A funding.
The round was led by the Michigan Angel Fund.
Led by Kiyomi Monro, CEO, BSI develops ultrafast lasers with adaptive capabilities producing pulses in the multi-femtosecond range used for industrial, scientific, medical, and defense applications. The company’s products are based on proprietary technology, called “MIIPS”, which provides automated measurement and compression of ultrafast laser pulses, automatically delivering optimized laser light to the target.
FinSMEs
01/10/2013